Product: EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
Reason for recall: Sub Potent Drug: Out of Specification (OOS)
Recall initiated: 20191121
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated